estrone has been researched along with olaparib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Li, J; Xia, Q; Xu, Y; Zhang, Q; Zhang, Z | 1 |
1 other study(ies) available for estrone and olaparib
| Article | Year |
|---|---|
Folliculin deficient renal cancer cells exhibit BRCA1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib.
Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Carcinoma, Renal Cell; Cell Line, Tumor; Estrone; Humans; Kidney Neoplasms; Mice; Mice, Nude; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors | 2021 |